Study Stopped
inclusion difficulties
Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury
MUSIC-TCNV
1 other identifier
interventional
11
1 country
1
Brief Summary
Paroxysmal sympathetic hyperactivity (PSH) is a frequent symptom after traumatic brain injury and concerns up to 30% of severely brain-injured patients. PSH is due to unbalanced autonomic nervous system activity, resulting in sympathetic surges causing hypertension, tachycardia, sweating and hypertonia. The affected patients suffer more pain, more cardiovascular distress, more infections and prolonged rehabilitation and mechanical ventilation; additionally it could lead to a worse outcome. Classical music was shown to reduce autonomic nervous system imbalance in healthy people and in many medical diseases. It could be a means to dampen sympathetic surges for brain-injured patients presenting with PSH, as well. Our study aims at demonstrating that early musical intervention, started with the weaning of sedation, can reduce both the prevalence and the severity of paroxysmal sympathetic hyperactivity in traumatic brain-injured patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2016
CompletedFirst Posted
Study publicly available on registry
May 26, 2016
CompletedStudy Start
First participant enrolled
November 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2019
CompletedNovember 17, 2021
November 1, 2016
2.1 years
May 23, 2016
November 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Paroxysmal Sympathetic Hyperactivity Assessment Measure [PSH-AM] (ranging from 0 to 29)
The PSH-AM combines the sum of Clinical Features Scale \[CFS\] (from 0 to 18) and the Diagnostic Likelihood tool \[DLT\] (from 0 to 11)
from desedation (Day 0) to Day 21.
Secondary Outcomes (7)
Area under the Clinical Features Scale curve
from Day 0 to Day 21.
Mean Analgesia Nociception Index
from Day 0 to Day 21.
Neurological Pupil Index
from Day 0 to Day 21.
Pain (Critical-Care Pain Observation Tool)
from Day 0 to Day 21.
Neurological outcome (Wessex Head Injury Matrix)
from Day 0 to Day 21.
- +2 more secondary outcomes
Study Arms (2)
Musical intervention
EXPERIMENTALMusic is provided through headphones: Two 30-min musical sessions per day (one in the morning and one in the evening) beginning at the onset of desedation (Day 0) until day 21. Both have inverted "U" shape.
Control
SHAM COMPARATORPatients wear headphones twice a day during 30 minutes, starting at the onset of desedation (Day 0) until day 21, but no music is provided (blank playlist): Sham
Interventions
Patients wear headphones twice a day during 30 minutes, starting at the onset of desedation (Day 0) until day 21, but no music is provided (blank playlist): Sham
Eligibility Criteria
You may qualify if:
- Severe traumatic brain injury (either initial Glasgow Coma Scale \< 8 or intracranial pressure \> 20mmHg for more than 20 min)
- National health service coverage
- Informed consent signed by next of kin
You may not qualify if:
- Non-traumatic brain injury
- Conditions interfering with measures: bilateral fixed pupils, temporal bone fracture including acoustic channel, eye trauma, previous eye surgery, otorrhagia, hypoacusis,
- Preexisting autonomic nervous system imbalance: severe diabetes, arrhythmias, pace maker, implantable defibrillator, cardiac transplantation
- Respiratory rate \< 9/min
- Patient subject to guardianship or wardship
- Pregnant or breastfeeding woman
- Current participation in another biomedical research protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Strasbourg, Francelead
- Fondation Apicilcollaborator
- MDMScollaborator
- Association française des traumatisés crâniens d'Alsacecollaborator
- Association strasbourgeoise des médecins et infirmiers en anesthésie réanimationcollaborator
Study Sites (1)
Service d'Anesthésie Réanimation- Hôpital de Hautepierre
Strasbourg, 67098, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2016
First Posted
May 26, 2016
Study Start
November 20, 2016
Primary Completion
January 4, 2019
Study Completion
December 18, 2019
Last Updated
November 17, 2021
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share